AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 160 filers reported holding AKERO THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $340,639 | -7.9% | 14,520 | -0.8% | 0.00% | -33.3% |
| Q1 2024 | $369,832 | +27.4% | 14,641 | +17.7% | 0.00% | +50.0% |
| Q4 2023 | $290,357 | -54.4% | 12,435 | -1.3% | 0.00% | -60.0% |
| Q3 2023 | $637,409 | +9.8% | 12,602 | +1.4% | 0.01% | 0.0% |
| Q2 2023 | $580,450 | +72.3% | 12,432 | +41.2% | 0.01% | +66.7% |
| Q1 2023 | $336,956 | -25.9% | 8,807 | +6.1% | 0.00% | -25.0% |
| Q4 2022 | $454,950 | – | 8,302 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 423,849 | $9,943,498 | 11.19% |
| Propel Bio Management, LLC | 327,752 | $7,689,062 | 4.99% |
| GENERAL ATLANTIC, L.P. | 5,233,989 | $122,789,382 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 625,087 | $14,664,541 | 3.46% |
| Yiheng Capital Management, L.P. | 1,434,179 | $33,645,839 | 2.71% |
| Redmile Group, LLC | 1,614,473 | $37,875,537 | 2.29% |
| Boxer Capital, LLC | 1,676,733 | $39,336,156 | 2.07% |
| RTW INVESTMENTS, LP | 5,431,985 | $127,434,368 | 1.97% |
| Logos Global Management LP | 800,000 | $18,768,000 | 1.52% |
| MPM BioImpact LLC | 385,990 | $9,055,325 | 1.41% |